Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.9

Ebola virus disease

Ebola virus disease is a filoviral hemorrhagic fever spread by direct contact with infected body fluids that progresses from a nonspecific febrile illness to diffuse hemorrhage, shock, and multiorgan failure with mortality that can reach 90 percent, and is treated with immediate isolation, supportive care, and a Zaire ebolavirus-specific monoclonal antibody.

11 min read4 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A filoviral hemorrhagic fever, most likely to be used as a biologic weapon along with Marburg virus: Ebola and Marburg are the two viral hemorrhagic fevers of greatest bioterrorism concern because of…

  • Epidemiology

    Endemic transmission occurs where the natural reservoir and vector exposures exist: in endemic areas, spread occurs through vectors, contact with bodily fluids, or fomites.

  • Risk factors

    Direct contact with the blood, feces, vomit, or other body fluids of an infected person: the essential mode of person-to-person transmission.

  • Pathophysiology

    Filovirus infection produces a systemic inflammatory and coagulopathic cascade: viral replication triggers a profound inflammatory response with endothelial injury.

  • Clinical features

    Abrupt onset of fever, headache, and myalgia: the earliest, nonspecific presenting symptoms after the incubation period.

  • Differential diagnosis

    Malaria: overlapping fever, headache, and myalgia, but distinguished by a history of mosquito exposure in a malaria-endemic area and intraerythrocytic parasites on blood smear rather than hemorrhage as the dominant late feature.

  • Diagnosis

    Ebola virus disease is confirmed by antigen and antibody assays and polymerase chain reaction of blood, with the specific test depending on the stage of infection; there is no separate formal…

  • Management

    First, place the patient in strict isolation with contact and droplet precautions before any further evaluation: protecting healthcare workers and other patients is the immediate priority given the…

  • Complications

    Shock: from combined hemorrhage and capillary leak; the proximate cause of death in most fatal cases.

  • Prognosis

    Mortality can reach 90%: among the highest case fatality rates of any recognized human infection, though early aggressive supportive care and prompt monoclonal antibody therapy for confirmed Zaire ebolavirus infection reduce that risk.

  • Prevention

    Vaccinate at-risk contacts and healthcare workers with the vaccine strictly indicated for Zaire ebolavirus: the only species with an established preventive vaccine; it does not cover other Ebola…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.